A multicenter, randomized, double-blind, placebo controlled study of aripiprazole in the treatment of patients with bipolar I disorder with a major depressive episode.
Phase of Trial: Phase III
Latest Information Update: 08 Nov 2013
At a glance
- Drugs Aripiprazole (Primary)
- Indications Bipolar I disorders; Depression; Major depressive disorder
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 01 Feb 2008 Results published (1101922)
- 08 Oct 2005 New trial record.